Jointyle provides a non‑contact, full‑body 360° skin scanning service that captures high‑resolution images in minutes and uses AI to detect early signs of skin cancer and other dermatological changes. The platform continuously maps skin health over time, delivers personalized risk reports, and offers dermatologist‑reviewed analysis with on‑demand spot checks for specific lesions.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals lack convenient access to comprehensive skin cancer screening, relying on occasional dermatologist visits that may miss early, subtle changes across the entire body. Early detection is critical, yet traditional exams are limited to visible areas and can be inconsistent over time.
Solution
Tyle offers a non‑contact, full‑body skin scanning service that captures a 360°, high‑resolution image of a user's skin in minutes. Advanced imaging collects thousands of data points, which are analyzed by AI models trained to identify early signs of skin cancer, aging, and other dermatological conditions, including changes invisible to the naked eye. The platform continuously maps and monitors skin over time, providing users with personalized insights and trend reports. All AI findings are reviewed by board‑certified dermatologists, ensuring clinical oversight and enabling referrals when necessary. Users can also request on‑demand spot checks for specific moles or lesions between full scans.
Target Audience
Primary customers are health‑conscious consumers seeking proactive skin health management and individuals at elevated risk for skin cancer who desire regular, comprehensive monitoring without frequent dermatologist visits.
Features
- Non‑contact, full‑body 360° imaging that captures detailed skin data in a single, quick session
- AI algorithms that detect subtle morphological changes and early cancer indicators across the entire body
- Continuous skin health monitoring with secure longitudinal mapping and trend visualization
- On‑demand spot‑check assessments for individual lesions between scheduled scans
- Personalized skin intelligence reports delivering actionable insights and risk assessments
- Physician‑reviewed analysis by board‑certified dermatologists for validated guidance